- Home
- RBOT vs IXHL Comparison
RBOT vs IXHL Comparison
Compare RBOT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- IXHL
- Stock Information
- Founded
- RBOT 2014
- IXHL 2001
- Country
- RBOT United States
- IXHL Australia
- Employees
- RBOT N/A
- IXHL N/A
- Industry
- RBOT Medical Specialities
- IXHL
- Sector
- RBOT Health Care
- IXHL
- Exchange
- RBOT Nasdaq
- IXHL Nasdaq
- Market Cap
- RBOT 61.4M
- IXHL 54.5M
- IPO Year
- RBOT N/A
- IXHL N/A
- Fundamental
- Price
- RBOT $6.34
- IXHL $0.53
- Analyst Decision
- RBOT Hold
- IXHL
- Analyst Count
- RBOT 1
- IXHL 0
- Target Price
- RBOT $7.00
- IXHL N/A
- AVG Volume (30 Days)
- RBOT 34.4K
- IXHL 114.5M
- Earning Date
- RBOT 11-11-2025
- IXHL 11-13-2025
- Dividend Yield
- RBOT N/A
- IXHL N/A
- EPS Growth
- RBOT N/A
- IXHL N/A
- EPS
- RBOT N/A
- IXHL N/A
- Revenue
- RBOT N/A
- IXHL $98,000.00
- Revenue This Year
- RBOT N/A
- IXHL $2,538.49
- Revenue Next Year
- RBOT N/A
- IXHL $249.95
- P/E Ratio
- RBOT N/A
- IXHL N/A
- Revenue Growth
- RBOT N/A
- IXHL N/A
- 52 Week Low
- RBOT $5.00
- IXHL $0.08
- 52 Week High
- RBOT $19.00
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- RBOT 46.32
- IXHL 48.15
- Support Level
- RBOT $5.58
- IXHL $0.51
- Resistance Level
- RBOT $5.99
- IXHL $0.59
- Average True Range (ATR)
- RBOT 0.39
- IXHL 0.05
- MACD
- RBOT 0.14
- IXHL -0.01
- Stochastic Oscillator
- RBOT 80.07
- IXHL 13.59
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.